CHICAGO, Oct. 30, 2024 /PRNewswire/ -- Ambetter of Illinois (Ambetter), a product offered by Centene Corporation (NYSE: CNC), and managed locally by Meridian Health Plan of Illinois, Inc. (Meridian), announced today the addition of Advocate Health Care to its network, which will further increase members' access to quality healthcare in the Chicagoland area. Ambetter members can now receive care at any of Advocate's 11 hospitals and 300 sites of care in Illinois, with 6,500 physicians, and 11,000 nurses. Ambetter provides insurance through the Health Insurance Marketplace (Healthcare.gov).
"We are pleased to add Advocate Health Care to our network because it gives our Marketplace members access to their large network of primary care physicians and extensive specialties including cancer care, heart & vascular care, orthopedics, and women's health, among others," said Cristal Gary, Meridian Plan President and CEO. "Meridian is proud to provide quality and network support to Ambetter of Illinois."
Access to Advocate Health Care providers and its services is effective immediately to all Ambetter of Illinois members, and to those who enroll in its plans during Open Enrollment for the Health Insurance Marketplace for Illinois, which runs from November 1, 2024, through January 15, 2025. Existing and new Ambetter of Illinois' members can make an appointment, find a provider, or review their benefits by logging into their account at ambetterofillinois.com.
Ambetter of Illinois, a product offered by a Centene Corporation (NYSE: CNC) company, which provides insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace®, will offer a variety of affordable health insurance plans for Illinois residents in plan year 2025. Open Enrollment for the Health Insurance Marketplace for Illinois runs from Nov. 1, 2024, through Jan. 15, 2025. Enroll by Dec. 15 for coverage starting Jan. 1, 2025.
Last Trade: | US$29.33 |
Daily Change: | 0.34 1.17 |
Daily Volume: | 16,287,624 |
Market Cap: | US$14.400B |
July 29, 2025 July 25, 2025 April 25, 2025 February 24, 2025 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load